New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Iterum Therapeutics plc
ITRM
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

43M

Biotechnology

Next Earning date - 12 Nov 2024

43M

Biotechnology

Next Earning date - 12 Nov 2024

1.88USD
Shape0.71 ( 60.68%)
favorite-chart

Relative Strenght

51
favorite-chart

Volume Buzz

32895%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

25%

Quote Panel

Shape
Updated October 25, 2024
1W 67.86 % 1M 79.05 % 3M 50.40 % 1Y 180.60 %

Key Metrics

Shape
  • Market Cap

    42.69M


  • Shares Outstanding

    22.71M


  • Share in Float

    21.95M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    1.88


  • Average Volume

    315043


  • Beta

    2.251


  • Range

    0.642-2.5


  • Industry

    Biotechnology


  • Website

    https://www.iterumtx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

16.29x

P/S Ratio

-2.85x

P/B Ratio

-2.0

Debt/Equity

-1081.6%

Net Margin

$-1.8

EPS

How ITRM compares to sector?

P/E Ratio

Relative Strength

Shape

ITRM

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$12M

ShapeNaN%

2025-Revenue

$0.56

Shape-85%

2025-EPS

$7M

Shape283%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

H.C. Wainwright

upgrade

Previous: Not converted

2024-02-07

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-2.38
vs 0.3

Q4.22

arrow
arrow

N/A

-0.41
vs -0.30

Q1.23

arrow
arrow

N/A

-0.78
vs -0.30

Q2.23

arrow
arrow

N/A

-0.95
vs -0.60

Q3.23

arrow
arrow

N/A

-0.30
vs -2.38

Q4.23

arrow
arrow

N/A

-0.94
vs -0.41

Q1.24

arrow
arrow

N/A

-0.46
vs -0.78

Q2.24

arrow
arrow

N/A

-0.30
vs -0.95

Q3.24

arrow
arrow

N/A

-0.17
vs -0.30

Q4.24

arrow
arrow

N/A

-0.20
vs -0.94

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

2.6M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-89%

-0.89
vs -0.15

Q4.22

arrow
arrow

-18%

-0.18
vs -0.89

Q1.23

arrow
arrow

-52%

-0.52
vs -0.18

Q2.23

arrow
arrow

-172%

-1.72
vs -0.52

Q3.23

arrow
arrow

-113%

-1.13
vs -1.72

Q4.23

arrow
arrow

+193%

1.93
vs -1.13

Q1.24

arrow
arrow

+115%

1.15
vs 1.93

Q2.24

arrow
arrow

+46%

0.46
vs 1.15

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

4

4
vs 29

-86%

Q4.22

arrow
arrow

3

3
vs 4

-25%

Q1.23

arrow
arrow

2

2
vs 3

-33%

Q2.23

arrow
arrow

2

2
vs 2

NA

Q3.23

arrow
arrow

2

2
vs 2

NA

Q4.23

arrow
arrow

2

2
vs 2

NA

Q1.24

arrow
arrow

2

2
vs 2

NA

Q2.24

arrow
arrow

1

1
vs 2

-50%

Earnings Growth

Latest News